Famciclovir for the Treatment of Acute Herpes Zoster: Effects on Acute Disease and Postherpetic Neuralgia: A Randomized, Double-Blind, Placebo-Controlled Trial

@article{Tyring1995FamciclovirFT,
  title={Famciclovir for the Treatment of Acute Herpes Zoster: Effects on Acute Disease and Postherpetic Neuralgia: A Randomized, Double-Blind, Placebo-Controlled Trial},
  author={Stephen K. Tyring and Rick A. Barbarash and J E Nahlik and Anthony L Cunningham and John E Marley and Meng Heng and T Jones and T L Rea and Ron J Boon and Robin L. Saltzman},
  journal={Annals of Internal Medicine},
  year={1995},
  volume={123},
  pages={89-96}
}
Herpes zoster (shingles) develops in as many as 20% of all persons [1]. The characteristic zoster rash is often accompanied by substantial pain, dysesthesias, and skin hypersensitivity. The unmet challenge in the management of patients with acute zoster is the alleviation of chronic pain. In many patients, pain resolves once the affected area of skin returns to normal. However, some patients continue to experience pain long after the lesions have healed; this pain is commonly called… Expand
Tolerability of Treatments for Postherpetic Neuralgia
TLDR
Treatment of established PHN is difficult and may require a holistic approach, although tricyclic antidepressants and gabapentin are the systemic agents with the most proven benefit, although opioids such as oxycodone and NMDA receptor antagonists such as ketamine may be useful in some people. Expand
Acyclovir with and without Prednisone for the Treatment of Herpes Zoster
TLDR
A clinical trial to determine the effect of adding corticosteroids to acyclovir for the treatment of herpes zoster and key study end points were measurements of pain and quality of life. Expand
Herpes zoster and postherpetic neuralgia: prevention and management.
TLDR
Evidence supports treating postherpetic neuralgia with tricyclic antidepressants, gabapentin, pregabalin, long-acting opioids, or tramadol; moderate evidence supports the use of capsaicin cream or a lidocaine patch as a second-line agent. Expand
Herpes zoster and postherpetic neuralgia: diagnosis and therapeutic considerations.
  • M. Roxas
  • Medicine
  • Alternative medicine review : a journal of clinical therapeutic
  • 2006
TLDR
The most effective conventional treatment options currently available are presented, as well as select botanical, nutritional, and other considerations that may be beneficial in the management of this condition. Expand
ACUTE HERPES ZOSTER AND POSTHERPETIC NEURALGIA
TLDR
The natural history and pathogenesis of HZ and PHN is reviewed, and approaches to treatment and prevention are critically evaluated, in immunocompetent patients. Expand
Management of herpes zoster and postherpetic neuralgia.
  • S. Tyring
  • Medicine
  • Journal of the American Academy of Dermatology
  • 2007
TLDR
There is a need for more effective agents to treat herpes zoster and postherpetic neuralgia and nonpharmacologic approaches may be considered and a pain-management specialist should be consulted. Expand
The effect of treating herpes zoster with oral acyclovir in preventing postherpetic neuralgia. A meta-analysis.
TLDR
Treatment of herpes zoster with 800 mg/d of oral acyclovir within 72 hours of rash onset may reduce the incidence of residual pain at 6 months by 46% in immunocompetent adults. Expand
Postherpetic neuralgia: impact of famciclovir, age, rash severity, and acute pain in herpes zoster patients.
TLDR
The results indicated that greater age, rash severity, and acute pain severity are risk factors for prolonged PHN and demonstrated that treatment of acute herpes zoster patients with famciclovir significantly reduces both the duration and prevalence of PHN. Expand
Effectiveness of antiviral treatment on acute phase of herpes zoster and development of post herpetic neuralgia: review of international publications.
TLDR
This review evaluates the effectiveness of antiviral drugs on the intensity of pain and progression of the rash during the acute phase of herpes zoster, and the frequency, intensity, and duration of post-herpetic neuralgia. Expand
The management of post-herpetic neuralgia
TLDR
This total duration of pain and pain at a single time point (3 months after onset) is suggested to be used as endpoints in clinical studies. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 32 REFERENCES
Effect of oral acyclovir on pain resolution in herpes zoster: A reanalysis
TLDR
It is found that the median duration of pain in acyclovir recipients was 20 days vs. 62 days for their placebo counterparts and the absence of pain at the onset of cutaneous herpes zoster did not preclude its later development. Expand
Acute herpetic and postherpetic neuralgia: Clinical review and current management
TLDR
This review summarizes current information on the epidemiology, clinical features, and pathology of herpes zoster and postherpetic neuralgia, and critically examines the accumulated experience with the various treatments. Expand
Oral acyclovir in the treatment of herpes zoster in general practice.
TLDR
Acyclovir reduced the extent and duration of the rash, the spread of the Rash to adjacent dermatomes and the incidence of disseminated lesions, and it shortened the period of new lesion formation and reduced the occurrence of ulceration in acute herpes zoster and postherpetic neuralgia. Expand
Oral acyclovir in the treatment of acute herpes zoster ophthalmicus.
TLDR
A ten-day course of treatment with oral acyclovir (600 mg, five times a day) is well-tolerated and significantly reduces the incidence and severity of the most common complications of herpes zoster ophthalmicus: dendritiform keratopathy, stromal keratitis, and uveitis. Expand
Human Infection with Herpes Zoster: Etiology, Pathophysiology, Diagnosis, Clinical Course, and Treatment
TLDR
Clinical features of herpes zoster may follow a progression through 3 stages, prodromal, acute, and chronic, and acyclovir is considered the drug of choice by most clinicians. Expand
The outcome of patients with herpes zoster.
TLDR
There is a continuous stream of publications, in the medical literature, devoted to the study of the results obtained in the treatment of herpes zoster, and no single method of treatment has produced more than temporary enthusiasm. Expand
Famciclovir, a new oral antiherpes drug: results of the first controlled clinical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patients.
  • H. Degreef
  • Medicine
  • International journal of antimicrobial agents
  • 1994
TLDR
Famciclovir, administered less frequently and at lower unit doses than acyclovir, is an effective treatment for patients with uncomplicated herpes zoster and was well tolerated with a safety profile comparable to that of acy Clovir. Expand
Postherpetic neuralgia. A review.
TLDR
It is reasonable to hope for a reduction in pain from severe to mild in two of three cases, and there is evidence to support the use of low doses of tricyclic antidepressants, especially amitriptyline hydrochloride, with gradual small increments, and also theUse of phenothiazines. Expand
Oral acyclovir for acute herpes zoster infections in immune-competent adults
TLDR
There were no significant differences in rash progression and pain response in patients with herpes zoster affecting the ophthalmic division of the trigeminal nerve in patients who received acyclovir compared to those who received placebo, and Haematological and biochemical safety monitoring data showed no treatment-related toxicity from acyClovir. Expand
Herpes zoster and postherpetic neuralgia
TLDR
The biology of varicella and zoster has been eloquently summarized by Weller and is obviously related to the widely recognized high incidence of zoster in patients with malignant diseases and iatrogenic immunosuppression. Expand
...
1
2
3
4
...